Little is known about the relationship between neuronal cell transplantation and endogenous neurogenesis after experimental stroke. We found previously that transplantation of neuronal precursors derived from BG01 human embryonic stem cells reduced infarct volume and improved behavioral outcome after distal middle cerebral artery occlusion (MCAO) in rats. In this study, transplantation was performed 14 d after distal MCAO and doublecortin (Dcx)-expressing cells in the subventricular zone (SVZ) and subgranular zone of dentate gyrus (SGZ) were counted 60 d post-transplant. Transplantation increased neurogenesis (Dcx expression) in ipsilateral SVZ, but not in contralateral SVZ or either SGZ, in both young adult (3 mo-old) and aged (24-mo-old) rats. These findings suggest that cell-based therapy for stroke may be associated with changes in endogenous adaptive processes, including neurogenesis.
INTRODUCTION
Cell-based therapy for stroke subsumes at least two possible approaches-enhancement of endogenous cytogenesis and transplantation of exogenous cells-both of which have shown success in animal models. A variety of drugs and growth factors promote endogenous neurogenesis and improve histological and functional outcome from experimental stroke (Kernie and Parent, 2010) , and a range of transplanted cell types are likewise effective (Locatelli et al., 2009) . However, little is understood about possible interactions between transplanted and endogenous neural precursor cells in stroke.
There are several reasons to think that crosstalk between exogenous and native neuroproliferative cells might be important. First, injury stimulates endogenous neurogenesis (Gould and Tanapat, 1997) , and transplantation by certain (e.g., intracerebral or intraventricular) routes necessarily induces at least some degree of injury. Second, transplantation may elicit an inflammatory response, and inflammation can modify endogenous neurogenesis (Whitney et al., 2009 ). Third, transplanted cells release growth and other soluble factors that may contribute to their beneficial effects after stroke (Li and Chopp, 2009) , and which are also known to promote neurogenesis (Bath and Lee, 2010) .
Previous studies support the notion that transplanted neural cells can modify endogenous neurogenesis in normal rodents. Intrahippocampal transplantation of glial-restricted progenitors from embryonic rat spinal cord or neural stem cells from mouse neural tube (Hattiangady et al., 2007) enhanced neurogenesis, measured by doublecortin (Dcx) staining, in dentate gyrus (DG) of middle-aged (12-month-old) rats. In a study of aged (22-monthold) rats, DG neurogenesis, detected by bromodeoxyuridine (BrdU) and Dcx staining, was increased following intraventricular administration of conditionally immortalized human fetal brain (CTX0E03) cells (Park et al., 2010) .
A single study has described a possible effect of neural cell transplantation on neurogenesis in cerebral ischemia. CTX0E03 cells were transplanted into rat putamen 4 wks after middle cerebral artery occlusion (MCAO) (Stroemer et al., 2009) . In contrast to most other reports (Arvidsson et al., 2002; Jin et al., 2001; Parent et al., 2002; Zhang et al., 2001 ), these investigators found that MCAO decreased, rather than increased, cell proliferation in the subventricular zone (SVZ), as measured by immunostaining for Ki67 antigen. Transplantation partly restored the number of Ki67-posiitve cells, from ~25% to ~50% of nonischemic control levels at 3 mo post-transplant, but the cell type affected was not examined. In addition, transplantation had no effect on infarct volume.
We found previously that intralesional transplantation of nestin/Sox2-immunoposiitve neuronal precursor cells (NPCs) derived from BG01 human embryonic stem cells (hESCs) 3 wks after distal MCAO in rats reduced infarct volume and improved behavioral outcome 4-9 wks post-transplant (Jin et al., 2010a) . In another study, we found that the salutary effects of transplantation occurred in both young adult (3-month-old) and aged (24-month-old) rats (Jin et al., 2010b) . Using the same model, we now report an effect of NPC transplantation following MCAO on endogenous neurogenesis in young and aged rats.
RESULTS
As reported previously (Jin et al., 2010b) , distal MCAO produced cerebral infarcts that occupied ~30% and ~40% of hemispheric volume in young adult (3-month-old) and aged (24-month-old) male Fisher-344 rats, respectively. Cultured NPCs were >90% nestin/Sox2-positive and >99% calbindin/GFAP/Oct4-negative at the time of transplantation, 14 d post-MCAO ( Figure 1A ). Based on previous findings (Jin et al., 2010a) Transplanted cells were detected by immunostaining for the human nuclear antigen, HuN. Most HuN-immunopositive cells surviving 60 d post-transplant were localized to the penumbra between normal brain tissue and the infarct cavity, and more HuNimmunopositive cells survived after transplantation into 3-month-old than 24-month-old rats ( Figure 1B-C) . To detect neuronal differentiation of transplanted cells, some brain sections through the cortical infarct site were stained with antibodies against both HuN and the early neuronal lineage marker, Dcx. HuN/Dcx-immunopositive cells were observed predominantly in the penumbra and infarct zone and not in adjacent normal cerebral cortex ( Figure 1D -E). HuN-immunoreactive cells were not detected in SGZ or SVZ, indicating that they did not migrate to and persist in these regions.
To determine the effect of NPC transplantation post-MCAO on neurogenesis in SGZ and SVZ, cells expressing the early neuronal lineage marker Dcx were counted in both regions, after vehicle or NPC treatment, and in 3-and 24-month-old rats (Figure 2A -C). Dcx expression declined with age, and was ~75% higher (p<0.0001) in 3-month-old rats and 65% higher (p<0001) in 24-month-old rats in the ipsilateral than in the contralateral SVZ and ~40% higher (p<0.001) in 24-month-old rats in the ipsilateral than in the contralateral SGZ. NPC transplantation produced a further increase in BrdU labeling, but only in SVZ, bỹ 30% (p<0.0005) in 3-month-old and ~50% (p<0.0001) in 24-month-old rats. Thus, MCAO increased the number of Dcx-positive cells in SVZ, and transplantation augmented this number further, as long as 60 d post-transplant.
Dcx is expressed in cells of neuronal lineage for days to weeks (Brown et al., 2003) , so the increased numbers of Dcx-positive cells observed 60 d post-transplant could reflect stimuation of neurogenesis any time during that interval. To determine if transplantation was still enhancing cytogenesis 60 d later, some rats were pulse-treated for 1 d with BrdU, which labels cells that undergo DNA replication within hours of its administration, and therefore reflects the current rate of cell division. Of note, new neurons in SVZ can express Dcx within 1 d of BrdU labeling and remain largely within SVZ for 1-3 d (Jin et al., 2003b) . Brain sections through the SVZ were stained for both BrdU and neuronal (Dcx), astroglial (glial fibrillary acidic protein, GFAP), or endothelial (lectin) lineage markers. BrdU labeled cells of all three lineages ( Figure 3A -C), but no transplant-induced increase in BrdU/Dcx, BrdU/GFAP, or BrdU/lectin double-labeled cells was detected ( Figure 3D-F) . Thus, the cytogenesis-enhancing effects of transplantation had ceased by 60 d, and must have been exerted earlier in the post-transplant interval.
DISCUSSION
Stem cell transplantation can restore function in rodent models of diabetes, immunodeficiency, and myocardial infarction, by stimulating the production of pancreatic β-cells (Urban et al., 2008) , lymphocytes (Carbonaro et al., 2008) , or endothelial cells (Yoshioka et al., 2005 ) from endogenous precursors. We reported previously that transplantation of human NPCs into rat brain following experimental stroke reduced infarct volume and improved behavioral outcome (Jin et al., 2010a; Jin et al., 2010b) . In the present study, we found that transplantation also stimulated neurogenesis in the SVZ ipsilateral to stroke, as demonstrated by increased numbers of cells expressing the early neuronal lineage marker Dcx 60 d post-transplant.
A small number of prior studies have documented increased neurogenesis (PSA-NCAM, BrdU/Dcx, or BrdU/NeuN-immunoreactive cells) in the SVZ (Yoo et al., 2008) or periinfarct region (Nakano-Doi et al., 2010; Taguchi et al., 2004) when non-neuronal cells (MSCs) were transplanted in rodents after stroke. In other studies, transplantation alone had no such effect, but the combination of MSCs and either a nitric oxide donor (Chen et al., 2004) or erythropoietin (Esneault et al., 2008) did. The previous study most closely related to ours in design involved intraputamenal delivery of conditionally immortalized human fetal brain (CTX0E03) cells into rat putamen 4 wks after MCAO (Stroemer et al., 2009) . The authors reported a stroke-induced decrease in cell proliferation (Ki67 antigen immunoreactivity) in SVZ, which was offset to some extent by transplantation, but did not identify the proliferative cell phenotype. In contrast, we transplanted hESC-derived NPCs, which were delivered into the infarct cavity, and found increased neurogenesis in SVZ. In addition, we observed NPC transplantation-induced enhancement of neurogenesis in both young adult and aged animals. Finally, we noted dissociation between the effects of transplantation on SVZ compared to SGZ neurogenesis, in that only the former was affected.
In light of our prior finding that the same NPC/Matrigel transplants improved outcome from stroke (Jin et al., 2010a; Jin et al., 2010b) , the question arises as to whether transplantinduced endogenous SVZ neurogenesis contributed to this improvement. We did not address this issue directly in the present study, but found previously that ablation of endogenous neurogenesis in transgenic mice expressing herpes simplex virus thymidine kinase under control of the Dcx promoter increases infarct size and exacerbates postischemic sensorimotor behavioral deficits (Jin et al., 2010c) ; therefore, a contribution of transplantenhanced neurogenesis to improved outcome is possible. Like the effects of transplantation on certain non-neuronal precursor cells (Urban et al., 2008; Yoshioka et al., 2005) , this may involve transplant-derived diffusible mediators. Further studies will be required to identify such factors.
The observation that transplantation stimulated neurogenesis in both young adult and aged rats merits comment. Clinical stroke is most common in the elderly, so experimental models in aged animals may have special relevance. We found previously that, notwithstanding an age-related decrement in basal endogenous neurogenesis (Jin et al., 2003a) and, in some cases, an age-dependent increase in stroke size (Jin et al., 2010b) , aged rats retain the ability to respond to either growth factors (Jin et al., 2003a) or cerebral ischemia (Won et al., 2006) with an increase in SVZ neurogenesis. Here we report that the same is true for the response to NPC transplantation. These findings argue against an entirely intrinsic, or cellautonomous, defect in neurogenesis due to age, and suggest instead that the extracellular environment may contribute to the observed limitations. If this is true, it bodes well for the potential clinical applicability of cell-based treatments directed against stroke.
EXPERIMENTAL PROCEDURE

Distal MCAO
All animal procedures were conducted in accordance with National Institutes of Health guidelines and with the approval of the Institutional Animal Care and Use Committee. Young adult (3-month-old) and aged (24-month-old) male Fisher-344 rats, obtained from the National Institute on Aging, were anesthetized with 4% isoflurane in 70% N 2 O/30% O 2 using a mask. Permanent distal MCAO was performed as described previously (Jin et al., 2010a) . A 2-cm incision was made under the surgical microscope between the left orbit and tragus, the temporal muscle was retracted laterally, and a 3-mm diameter craniotomy was made just rostral to the foramen ovale. The dura was incised with a 26-gauge needle and the MCA was exposed and occluded by electrocoagulation without damaging the brain surface. The temporal muscle was repositioned and the skin was closed. Rectal temperature was maintained at 37 ± 0.2°C throughout with a heating blanket. In sham-operated controls the MCA was visualized but not occluded.
Cell culture
BG01 hESC-derived NPCs were obtained from Aruna Biomedical Inc. (Athens, GA) and propagated in our laboratory. Cells were seeded on polyornithine-and laminin-coated plastic dishes and cultured in proliferation medium (Neurobasal medium with B27 supplementation, 2 mM L-glutamine, 50 µg/ml Pen Strep, 10 ng/ml leukemia inhibitory factor, and 20 ng/ml fibroblast growth factor-2 (Shin et al., 2006) . Upon reaching 90-100% confluence, cells were triturated, centrifuged at 200 × g for 4 min, suspended in fresh medium, and replated.
Cell transplantation
NPCs (1.2×10 5 cells/µl in 15 µl of Matrigel) were injected into the cortical infarct cavity over 5 min using a Hamilton syringe, after which the needle was left in place for 15 min more before being slowly withdrawn. Control rats received injections of artificial cerebrospinal fluid vehicle (125 mM NaCl, 2.4 mM KCl, 1.2 mM NaH 2 PO 4 , 25 mM NaHCO 3 , 25 mM glucose, 1 mM CaCl 2 , 2 mM MgCl 2 ). Bone wounds were closed with bone wax, anesthesia was discontinued, and rats were returned to their cages. BrdU (two 50-mg/kg intraperitoneal doses given 8 hr apart) was administered 59 days post-transplantation and rats were euthanized 1 day later.
Immunohistochemistry
Brains were perfused with 0.9% saline and 4% paraformaldehyde in PBS (pH 7.5) and embedded in paraffin, and 6-µm coronal and sagittal sections were prepared. Immunohistochemistry was performed as described previously (Jin et al., 2010a; Jin et al., 2010c) . To detect BrdU labeling, sections were treated with 50% formamide, 280 mM NaCl, and 30mM sodium citrate at 65°C for 2 h, incubated in 2 M HCl at 37°C for 30 min, and rinsed in 0.1M boric acid (pH 8.5) at room temperature for 10 min. Primary antibodies were sheep polyclonal anti-BrdU (Biodesign, 1:1000), goat polyclonal anti-Dcx (Santa Cruz Biotechnology, 1:500), rabbit polyclonal anti-GFAP (Sigma-Aldrich, 1:400), and mouse monoclonal anti-HuN (Chemicon, 1:300). FITC-labeled Lycopersicon esculentum (tomato) lectin (Vector, 1:300) was used for vessel staining. Secondary antibodies were Alexa Fluro 488-, or 594-or 647-conjugated donkey anti-sheep, anti-goat, anti-rabbit, or anti-mouse IgG (Molecular Probes, 1:200-500). Fluorescence signals were detected using an LSM 510 NLO Confocal Scanning System mounted on an Axiovert 200 inverted microscope (Carl Zeiss, Thornwood, NY) equipped with a two-photon Chameleon laser (Coherent, Santa Clara, CA). Images were acquired using LSM 510 Imaging Software (Carl Zeiss). Controls included omitting or preabsorbing the primary or omitting the secondary antibody.
Cell counting
Cell counts were performed by an observer blinded to the experimental conditions. Singlelabeled cells were counted in five to seven diaminobenzidine-stained, 50-µm coronal sections per animal, spaced 200 µm apart. Cells were counted under high power on a Nikon E800 microscope with Magnifire digital camera with the image displayed on a computer monitor. Double-labeled cells were counted in three to five 6-µm coronal sections per animal, spaced 70 µm apart, using an LSM 510 NLO Confocal Scanning System mounted on an Axiovert 200 inverted microscope.
Statistical Analyses
Quantitative data were expressed as mean ± SEM from 6-9 animals and differences between means were analyzed by t-test, with p values <0.05 considered significant. Immunostaining for BrdU and cell lineage markers in SVZ, 74 d after MCAO and 60 d after NPC transplantation. Sections through SVZ of the ischemic hemisphere from 3-month-old rats receiving NPC transplants were stained with anti-BrdU (red) and either anti-Dcx (A), anti-GFAP (B), or Lycopersicon esculentum (tomato) lectin (C) (green). Corresponding counts of doubly immunopositive cells (means ± SEM; n=6-8 animals per condition) are shown in (D), (E), and (F), respectively. None of the comparisons between untransplanted (Veh) and transplanted (Cell) conditions was significant at the p<0.05 level.
ABBREVIATIONS
